Zimmer Biomet officer plans $295K stock sale

Officer-level holder of ZBH common stock has filed a Rule 144 notice to sell 3,000 shares valued at about $295,000 through a broker.

Rhea-AI Filing Summary

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is the issuer for a planned sale of restricted securities reported under Rule 144 on behalf of officer Chad F. Phipps. The notice covers 3,000 shares of common stock, with an indicated value of $295,050.30, to be sold through Fidelity Brokerage Services LLC on the NYSE on September 4, 2026.

The shares originated from multiple issuances by the company between 2019 and 2024, including dividend reinvestments and restricted stock vesting granted as compensation.

Key Figures

Shares to be sold: 3,000 shares Aggregate market value: $295,050.30 Planned sale date: September 4, 2026 +2 more

5 metrics

Shares to be sold 3,000 shares Common stock to be sold under Rule 144 through Fidelity Brokerage Services LLC

Aggregate market value $295,050.30 Value associated with the 3,000 ZBH common shares listed for sale

Planned sale date September 4, 2026 Date listed for the NYSE sale of the 3,000 shares

Dividend reinvestment acquisition example 76 shares Acquired via dividend reinvestment from issuer on April 26, 2023

Restricted stock vesting 2024 985 shares Restricted stock vesting from issuer on February 25, 2024 as compensation

Key Terms

Rule 144, Dividend Reinvestment, Restricted Stock Vesting, Compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Dividend Reinvestment financial

"Common | 10/29/2019 | Dividend Reinvestment | Issuer"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Restricted Stock Vesting financial

"Common | 02/26/2020 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"02/26/2020 | Restricted Stock Vesting | Issuer | | | 1145 | 02/26/2020 | Compensation"

FAQ

What does the Form 144 filing disclose for ZBH?

It discloses a planned Rule 144 sale of 3,000 shares of Zimmer Biomet Holdings, Inc. common stock, with an indicated value of $295,050.30, to be sold on the NYSE on September 4, 2026 through Fidelity Brokerage Services LLC.

Who is the security holder in the ZBH Form 144 notice?

The notice is filed for the account of Chad F. Phipps, identified as an officer of Zimmer Biomet Holdings, Inc., with Fidelity Brokerage Services LLC acting as the broker and attorney-in-fact signing on his behalf.

How many ZBH shares are planned to be sold and at what value?

The filing lists 3,000 shares of Zimmer Biomet common stock with an indicated value of $295,050.30. The shares are to be sold on the NYSE, as stated in the securities information section.

How were the ZBH shares in this Form 144 acquired?

The shares came from multiple issuances by the issuer between 2019 and 2024, including dividend reinvestment transactions and restricted stock vesting granted as compensation, such as 1,145 shares on February 26, 2020 and 985 shares on February 25, 2024.

What role does Fidelity Brokerage Services LLC play in the ZBH Form 144?

Fidelity Brokerage Services LLC is listed as the broker for the planned sale of 3,000 ZBH common shares and signed the notice on September 4, 2026 via Daniel Tucci as a duly authorized representative and attorney-in-fact for Chad Phipps.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:02 PM Accepted by SEC EDGAR 09/04/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001346672
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZIMMER BIOMET HOLDINGS, INC.
SEC File Number	001-16407
Address of Issuer	345 EAST MAIN STREET WARSAW INDIANA 46580
Phone	5742676131
Name of Person for Whose Account the Securities are To Be Sold	Phipps Chad F
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	295050.30	190737689	09/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/29/2019	Dividend Reinvestment	Issuer			66	10/29/2019	Cash
Common	01/29/2020	Dividend Reinvestment	Issuer			60	01/29/2020	Cash
Common	02/26/2020	Restricted Stock Vesting	Issuer			1145	02/26/2020	Compensation
Common	07/29/2020	Dividend Reinvestment	Issuer			70	07/29/2020	Cash
Common	10/28/2020	Dividend Reinvestment	Issuer			73	10/28/2020	Cash
Common	01/27/2021	Dividend Reinvestment	Issuer			63	01/27/2021	Cash
Common	02/26/2021	Restricted Stock Vesting	Issuer			204	02/26/2021	Compensation
Common	04/28/2021	Dividend Reinvestment	Issuer			56	04/28/2021	Cash
Common	07/28/2021	Dividend Reinvestment	Issuer			61	07/28/2021	Cash
Common	10/27/2021	Dividend Reinvestment	Issuer			67	10/27/2021	Cash
Common	04/26/2023	Dividend Reinvestment	Issuer			76	04/26/2023	Cash
Common	07/27/2023	Dividend Reinvestment	Issuer			74	07/27/2023	Cash
Common	02/25/2024	Restricted Stock Vesting	Issuer			985	02/25/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Chad Phipps
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)